In this episode, Michelle delves into the latest advancements in AI, starting with OpenAI's release of ChatGPT o3, which emphasizes deliberative alignment to enhance AI-human interactions. She then highlights Masayoshi Son's significant investment in AI hardware, reflecting a strategic push towards advancing AI capabilities. The episode also covers Tetsuwan Scientific's innovative use of robotic AI in scientific research, showcasing its potential to revolutionize data analysis and experimentation. Additionally, Michelle explores AI applications in healthcare at Stanford Medicine, discussing how AI is transforming patient care and medical research. The episode concludes with a wrap-up of these key developments in AI.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related